These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21106295)

  • 1. Methods of detection of circulating melanoma cells: a comparative overview.
    Nezos A; Msaouel P; Pissimissis N; Lembessis P; Sourla A; Armakolas A; Gogas H; Stratigos AJ; Katsambas AD; Koutsilieris M
    Cancer Treat Rev; 2011 Jun; 37(4):284-90. PubMed ID: 21106295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients.
    Quaglino P; Osella-Abate S; Cappello N; Ortoncelli M; Nardò T; Fierro MT; Cavallo F; Savoia P; Bernengo MG
    Melanoma Res; 2007 Apr; 17(2):75-82. PubMed ID: 17496782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
    Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current biological markers of cutaneous melanoma progression].
    Stoitchkov K; Le Bricon T
    Ann Biol Clin (Paris); 2000; 58(2):157-65. PubMed ID: 10760702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of occult melanoma cells in sentinel lymph nodes and blood.
    Reintgen DS; Conrad AJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 4):S11-5. PubMed ID: 9122728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
    Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
    Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction.
    Tobal K; Sherman LS; Foss AJ; Lightman SL
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2622-5. PubMed ID: 8344785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
    Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
    Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma.
    Samija I; Lukac J; Marić-Brozić J; Buljan M; Alajbeg I; Kovacević D; Situm M; Kusić Z
    Melanoma Res; 2010 Aug; 20(4):293-302. PubMed ID: 20357686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence.
    Hoon DS; Bostick P; Kuo C; Okamoto T; Wang HJ; Elashoff R; Morton DL
    Cancer Res; 2000 Apr; 60(8):2253-7. PubMed ID: 10786692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular diagnostic detection of circulating tumor cells and their prognostic implications].
    Nakanishi H; Tatematsu M
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):257-65. PubMed ID: 9051125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the stem cell marker nestin in peripheral blood of patients with melanoma.
    Fusi A; Ochsenreither S; Busse A; Rietz A; Keilholz U
    Br J Dermatol; 2010 Jul; 163(1):107-14. PubMed ID: 20346020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.
    Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG
    Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular diagnostics of malignant melanoma: molecular staging, minimal residual disease].
    Tímár J; Csuka O
    Magy Onkol; 2003; 47(1):63-6. PubMed ID: 12704457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of circulating neoplastic cells by reverse transcriptase and polymerase chain reaction in melanoma].
    Tessier MH; Denis MG; Lustenberger P; Dreno B
    Ann Dermatol Venereol; 1997; 124(9):607-11. PubMed ID: 9739921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnostics in melanoma.
    Carlson JA; Ross JS; Slominski A; Linette G; Mysliborski J; Hill J; Mihm M
    J Am Acad Dermatol; 2005 May; 52(5):743-75; quiz 775-8. PubMed ID: 15858465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
    Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA
    Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microphthalmia-associated transcription factor and tyrosinase as markers of melanoma cells in blood of patients with melanoma.
    Samija I; Lukac J; Marić-Brozić J; Kusić Z
    Croat Med J; 2004 Apr; 45(2):142-8. PubMed ID: 15103749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients.
    Mellado B; Gutierrez L; Castel T; Colomer D; Fontanillas M; Castro J; Estapé J
    Clin Cancer Res; 1999 Jul; 5(7):1843-8. PubMed ID: 10430090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.
    Ghossein RA; Carusone L; Bhattacharya S
    In Vivo; 2000; 14(1):237-50. PubMed ID: 10757082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.